SC-514 is primarily used in research settings as a selective inhibitor of IKK-2, an enzyme involved in the NF-kappaB signaling pathway. This pathway plays a critical role in regulating immune response, inflammation, and cell survival. By inhibiting IKK-2, SC-514 helps researchers study the effects of blocking this pathway in various cellular processes. It is particularly useful in understanding inflammatory diseases, such as arthritis, and in exploring potential therapeutic strategies. Additionally, SC-514 is employed in laboratory experiments to investigate the role of NF-kappaB in cancer development and progression, providing insights into potential targets for cancer treatment. Its application is limited to experimental studies and is not used in clinical or therapeutic contexts.